|Bid||164.51 x 1200|
|Ask||164.55 x 800|
|Day's Range||163.63 - 165.95|
|52 Week Range||133.65 - 179.92|
|Beta (5Y Monthly)||0.70|
|PE Ratio (TTM)||24.72|
|Earnings Date||Oct. 19, 2021|
|Forward Dividend & Yield||4.24 (2.59%)|
|Ex-Dividend Date||Aug. 23, 2021|
|1y Target Est||188.88|
23andMe Co-Founder & CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to discuss the future of personal genomics.
Dr. Howard Forman, Yale Radiology and Public Health Professor joins Yahoo Finance’s Anjalee Khemlani and the Yahoo Finance Live panel with the latest COVD-19 vaccine update.
In a historically expensive market, with top stocks across a range of sectors competing for your attention, sometimes it's difficult to figure out which are the best companies for your investment portfolio. This is no small accomplishment, especially when you consider that the global pharmaceutical market was worth $1.3 trillion as of 2020, and is on track to reach a valuation of more than $1.7 trillion by the year 2025.